Search Count: 9
 |
Sars-Cov-2 Mpro (Omicron, P132H+T169S) In Complex With Alpha-Ketoamide 13B-K
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-11-13 Classification: VIRAL PROTEIN Ligands: O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-13
Ligands: O6K
 |
Sars-Cov-2 Mpro (Omicron,P132H) In Complex With Alpha-Ketoamide 13B-K At Ph 8.5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-11-13 Classification: VIRAL PROTEIN Ligands: O6K, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-11-13
Ligands: O6K, CL
 |
Crystal Structure Of Sars-Cov-2 Mpro-Q189K Mutant In Complex With 13B-K
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN Ligands: O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-08-07
Ligands: O6K
 |
Crystal Structure Of Sars-Cov-2 Mpro-H172Y Mutant In Complex With 13B-K
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2024-08-07 Classification: ANTIVIRAL PROTEIN Ligands: O6K, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-08-07
Ligands: O6K, CL
 |
Crystal Structure Of Sars-Cov-2 Mpro-S144A Mutant In Complex With 13B-K
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-02-07 Classification: ANTIVIRAL PROTEIN Ligands: O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-07
Ligands: O6K
 |
Sars-Cov-2 Mpro (Omicron, P132H) In Complex With Alpha-Ketoamide 13B-K At Ph 6.5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2023-11-29 Classification: VIRAL PROTEIN Ligands: O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-11-29
Ligands: O6K
 |
Crystal Structures Of Diastereomer (S,S,S)-13B (13B-K) In Complex With The Sars-Cov-2 Mpro
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2022-10-12 Classification: ANTIVIRAL PROTEIN Ligands: O6K, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-10-12
Ligands: O6K, CL
 |
Crystal Structure (Monoclinic Form) Of The Complex Resulting From The Reaction Between Sars-Cov-2 (2019-Ncov) Main Protease And Tert-Butyl (1-((S)-1-(((S)-4-(Benzylamino)-3,4-Dioxo-1-((S)-2-Oxopyrrolidin-3-Yl)Butan-2-Yl)Amino)-3-Cyclopropyl-1-Oxopropan-2-Yl)-2-Oxo-1,2-Dihydropyridin-3-Yl)Carbamate (Alpha-Ketoamide 13B)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2020-03-04 Classification: VIRAL PROTEIN Ligands: DMS, O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
Ligands: DMS, O6K
 |
Crystal Structure (Orthorhombic Form) Of The Complex Resulting From The Reaction Between Sars-Cov-2 (2019-Ncov) Main Protease And Tert-Butyl (1-((S)-1-(((S)-4-(Benzylamino)-3,4-Dioxo-1-((S)-2-Oxopyrrolidin-3-Yl)Butan-2-Yl)Amino)-3-Cyclopropyl-1-Oxopropan-2-Yl)-2-Oxo-1,2-Dihydropyridin-3-Yl)Carbamate (Alpha-Ketoamide 13B)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2020-03-04 Classification: VIRAL PROTEIN Ligands: O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
Ligands: O6K